Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -248.63% is 261% below its 5-year average of -68.94%, near the low end of its 5-year range (-248.63%–-7.14%).
77.90% below its 12-month average of -139.76%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -33.41%.
RETURN ON ASSETS (ROA)
-248.63%
RETURN ON ASSETS (ROA) AVG TTM
-139.76%
RETURN ON ASSETS (ROA) AVG 3Y
-97.50%
RETURN ON ASSETS (ROA) AVG 5Y
-68.94%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-77.90%
CURRENT VS 3Y AVG
-155.01%
CURRENT VS 5Y AVG
-260.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.75%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-683.09%
vs the sector median at left
LeonaBio, Inc.
Market Cap
$22.36M
Return on Assets (ROA)
-248.63%
TTM Avg
-139.76%
3Y Avg
-97.50%
5Y Avg
-68.94%
Market Cap
$22.11M
Return on Assets (ROA)
-13.57%
TTM Avg
-12.25%
3Y Avg
-12.55%
5Y Avg
-25.19%
Market Cap
$21.84M
Return on Assets (ROA)
-228.73%
TTM Avg
-145.44%
3Y Avg
-152.25%
5Y Avg
-187.73%
Market Cap
$22.93M
Return on Assets (ROA)
-75.43%
TTM Avg
-148.63%
3Y Avg
-74.35%
5Y Avg
-49.59%
Market Cap
$21.37M
Return on Assets (ROA)
-173.14%
TTM Avg
-158.95%
3Y Avg
-120.45%
5Y Avg
-102.27%
Market Cap
$23.92M
Return on Assets (ROA)
181.24%
TTM Avg
65.61%
3Y Avg
3.99%
5Y Avg
-7.40%
Market Cap
$20.10M
Return on Assets (ROA)
-393.39%
TTM Avg
-225.59%
3Y Avg
-343.91%
5Y Avg
-343.91%
Market Cap
$20.23M
Return on Assets (ROA)
-188.98%
TTM Avg
-90.06%
3Y Avg
-67.42%
5Y Avg
-51.71%
Market Cap
$24.61M
Return on Assets (ROA)
-40.73%
TTM Avg
-51.29%
3Y Avg
-88.21%
5Y Avg
-85.48%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.36M | -248.63% | -139.76% | -97.50% | -68.94% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | -13.57% | -12.25% | -12.55% | -25.19% |
| Modular Medical, Inc. (MODD)vs › | $21.84M | -228.73% | -145.44% | -152.25% | -187.73% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.93M | -75.43% | -148.63% | -74.35% | -49.59% |
| Quantum BioPharma Ltd. (QNTM)vs › | $21.37M | -173.14% | -158.95% | -120.45% | -102.27% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.92M | 181.24% | 65.61% | 3.99% | -7.40% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.10M | -393.39% | -225.59% | -343.91% | -343.91% |
| NextCure, Inc. (NXTC)vs › | $20.23M | -188.98% | -90.06% | -67.42% | -51.71% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.61M | -40.73% | -51.29% | -88.21% | -85.48% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.79M | -116.81% | -53.20% | -39.87% | -35.95% |
ROA
-248.6%
ROE
-421.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -114.60% |
| 2024-12-31 | -164.92% |
| 2023-12-31 | -73.43% |
| 2022-12-31 | -37.05% |
| 2021-12-31 | -16.52% |
| 2020-12-31 | -7.14% |
| 2019-12-31 | -235.77% |
| 2018-12-31 | -103.32% |
